Literature DB >> 11181795

Kinetics of connective tissue growth factor expression during experimental proliferative glomerulonephritis.

Yasuhiko Ito1,2, Roel Goldschmeding1,3, Richard J Bende1, Nike Claessen1, M Anwar Chand1, Livio Kleij4, Ton J Rabelink4, Jan J Weening1, Jan Aten1.   

Abstract

Connective tissue growth factor (CTGF) is a member of the CCN family of immediate early genes, which are involved in cell proliferation, migration, and matrix production. Recently, CTGF was observed to be strongly upregulated in human proliferative and fibrogenic renal disease. By in situ hybridization and reverse transcriptase-PCR, the expression of CTGF was investigated in experimental proliferative glomerulonephritis induced by injection of anti-Thy-1.1 antibody in the rat. CTGF expression in cultured rat mesangial cells and glomerular visceral epithelial cells (GVEC) was studied in response to transforming growth factor beta (TGF-beta), an essential pathogenetic factor in this model. In normal rat kidneys, only some GVEC expressed CTGF mRNA. In anti-Thy-1.1 nephritis, CTGF mRNA expression was strongly increased in extracapillary and mesangial proliferative lesions and in areas of periglomerular fibrosis. Early glomerular CTGF overexpression in GVEC coincided with a striking upregulation of TGF-beta2 and to a lesser extent of TGF-beta3. Glomerular CTGF mRNA expression was maximal at day 7, in association with increased TGF-beta1 mRNA and protein expression. CTGF mRNA overexpression by parietal epithelial cells preceded the periglomerular appearance of alpha-smooth muscle actin-positive fibroblasts. In cultured mesangial cells, TGF-beta1, -beta2, and -beta3 transiently increased the CTGF/glyceraldehyde phosphate dehydrogenase mRNA ratio up to threefold versus control at 4 h. In GVEC, upregulation of CTGF mRNA by these TGF-beta isoforms was more sustained, being 8- to 16-fold versus control at 24 h. The kinetics of CTGF expression strongly suggest a role in glomerular repair, possibly downstream of TGF-beta, in this model of transient renal injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181795     DOI: 10.1681/ASN.V123472

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  18 in total

1.  CCN5 Expression in mammals. II. Adult rodent tissues.

Authors:  Mark R Gray; Jennifer A Malmquist; Matthew Sullivan; Michael Blea; John J Castellot
Journal:  J Cell Commun Signal       Date:  2007-11-13       Impact factor: 5.782

Review 2.  The enigmatic parietal epithelial cell is finally getting noticed: a review.

Authors:  Takamoto Ohse; Jeffrey W Pippin; Alice M Chang; Ronald D Krofft; Jeffrey H Miner; Michael R Vaughan; Stuart J Shankland
Journal:  Kidney Int       Date:  2009-10-21       Impact factor: 10.612

3.  Attenuating effect of Fufang Xueshuantong Capsule on kidney function in diabetic nephropathy model.

Authors:  Qian Zhang; Xinhua Xiao; Ming Li; Wenhui Li; Miao Yu; Huabing Zhang; Xiaofang Sun; Lili Mao; Hongding Xiang
Journal:  J Nat Med       Date:  2012-03-21       Impact factor: 2.343

Review 4.  Molecular pathways involved in loss of graft function in kidney transplant recipients.

Authors:  Valeria R Mas; Kellie J Archer; Mariano Scian; Daniel G Maluf
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

5.  Balanced regulation of the CCN family of matricellular proteins: a novel approach to the prevention and treatment of fibrosis and cancer.

Authors:  Bruce L Riser; Jeffrey L Barnes; James Varani
Journal:  J Cell Commun Signal       Date:  2015-12-23       Impact factor: 5.782

6.  Alteration of podocytes in a murine model of crescentic glomerulonephritis.

Authors:  Valérie Besse-Eschmann; Michel Le Hir; Nicole Endlich; Karlhans Endlich
Journal:  Histochem Cell Biol       Date:  2004-08       Impact factor: 4.304

Review 7.  The emerging role of coagulation proteases in kidney disease.

Authors:  Thati Madhusudhan; Bryce A Kerlin; Berend Isermann
Journal:  Nat Rev Nephrol       Date:  2015-11-23       Impact factor: 28.314

8.  Angiotensin II increases connective tissue growth factor in the kidney.

Authors:  Monica Rupérez; Marta Ruiz-Ortega; Vanesa Esteban; Oscar Lorenzo; Sergio Mezzano; Juan Jose Plaza; Jesús Egido
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

9.  Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.

Authors:  Andrea Hartner; Karl F Hilgers; Markus Bitzer; Roland Veelken; Harald O Schöcklmann
Journal:  J Mol Med (Berl)       Date:  2002-12-14       Impact factor: 4.599

10.  Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease?

Authors:  Andrew Leask; Sunil K Parapuram; Xu Shi-Wen; D J Abraham
Journal:  J Cell Commun Signal       Date:  2009-01-21       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.